speb/financial-data huggingface dataset:
SBIO.V income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -3347114.00
SBIO.V cash_flow (quarterly, 2025-09-30) — Net Intangibles Purchase And Sale: -42664.00
SBIO.V income_statement (quarterly, 2025-09-30) — Net Interest Income: -309447.00
SBIO.V cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -1401879.00
SBIO.V cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -1401879.00
SBIO.V income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -309447.00
SBIO.V cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -84.00
SBIO.V balance_sheet (quarterly, 2025-09-30) — Net PPE: 2079244.00
SBIO.V balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -10276449.00
SBIO.V balance_sheet (quarterly, 2025-09-30) — Non Current Accounts Receivable: 31285.00
SBIO.V balance_sheet (quarterly, 2025-09-30) — Non Current Note Receivables: 450465.00
SBIO.V income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -2790377.00
SBIO.V income_statement (quarterly, 2025-09-30) — Normalized Income: -3347624.34
SBIO.V cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 1241469.00
SBIO.V cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 2239.00
SBIO.V income_statement (quarterly, 2025-09-30) — Operating Income: -3011210.00
SBIO.V income_statement (quarterly, 2025-09-30) — Operating Revenue: 8208049.00
SBIO.V balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 50989645.00
SBIO.V balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 479715.00
SBIO.V balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 5270.00
SBIO.V balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 1824414.00
SBIO.V income_statement (quarterly, 2025-09-30) — Other Gand A: 1355015.00
SBIO.V income_statement (quarterly, 2025-09-30) — Other Income Expense: -7089.00
SBIO.V balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 199919.00
SBIO.V cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 76408.00
SBIO.V income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: -7735.00
SBIO.V income_statement (quarterly, 2025-09-30) — Other Special Charges: -646.00
SBIO.V balance_sheet (quarterly, 2025-09-30) — Payables: 13292352.00
SBIO.V balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 13377648.00
SBIO.V income_statement (quarterly, 2025-09-30) — Pretax Income: -3327746.00
SBIO.V balance_sheet (quarterly, 2025-09-30) — Properties: 0.00
SBIO.V cash_flow (quarterly, 2025-09-30) — Purchase Of Intangibles: -42664.00
SBIO.V balance_sheet (quarterly, 2025-09-30) — Receivables: 7784011.00
SBIO.V income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 3391058.00
SBIO.V income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 228568.00
SBIO.V income_statement (quarterly, 2025-09-30) — Rent And Landing Fees: 222440.00
SBIO.V income_statement (quarterly, 2025-09-30) — Rent Expense Supplemental: 222440.00
SBIO.V cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -207432.00
SBIO.V income_statement (quarterly, 2025-09-30) — Research And Development: 1778017.00
SBIO.V balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -22849211.00
SBIO.V income_statement (quarterly, 2025-09-30) — Salaries And Wages: 77901.00
SBIO.V income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 4166260.00
SBIO.V income_statement (quarterly, 2025-09-30) — Selling General And Administration: 5821616.00
SBIO.V balance_sheet (quarterly, 2025-09-30) — Share Issued: 50989645.00
SBIO.V income_statement (quarterly, 2025-09-30) — Special Income Charges: 646.00
SBIO.V cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 80337.00
SBIO.V balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: -7597756.00
SBIO.V balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -10276449.00
SBIO.V income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 135.66
SBIO.V income_statement (quarterly, 2025-09-30) — Tax Provision: 19368.00
SBIO.V income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.21
SBIO.V balance_sheet (quarterly, 2025-09-30) — Total Assets: 15480183.00
SBIO.V balance_sheet (quarterly, 2025-09-30) — Total Capitalization: -7163026.00
SBIO.V balance_sheet (quarterly, 2025-09-30) — Total Debt: 9481291.00
SBIO.V balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: -7597756.00
SBIO.V income_statement (quarterly, 2025-09-30) — Total Expenses: 11219259.00
SBIO.V balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 23077939.00
SBIO.V balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 5239687.00
SBIO.V balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 2252390.00
SBIO.V income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -3011210.00
SBIO.V balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 53000.00
SBIO.V income_statement (quarterly, 2025-09-30) — Total Unusual Items: 646.00
SBIO.V income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 646.00
SBIO.V balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 0.00
SBIO.V balance_sheet (quarterly, 2025-09-30) — Working Capital: -10585053.00
SBIO.V income_statement (annual, 2025-12-31) — +Operating Expense: 31903573.00
SBIO.V income_statement (quarterly, 2025-12-31) — +Operating Expense: 8126808.00
SBIO.V income_statement (annual, 2025-12-31) — +Total Revenue: 38231397.00
SBIO.V income_statement (quarterly, 2025-12-31) — +Total Revenue: 9778763.00
SBIO.V balance_sheet (annual, 2025-12-31) — Accounts Payable: 15227328.00
SBIO.V balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 15227328.00
SBIO.V balance_sheet (annual, 2025-12-31) — Accounts Receivable: 12969867.00
SBIO.V balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 12969867.00
SBIO.V balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -2510749.00
SBIO.V balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -2510749.00
SBIO.V balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -158245.00
SBIO.V balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -158245.00
SBIO.V income_statement (annual, 2025-12-31) — Amortization: 172346.00
SBIO.V income_statement (quarterly, 2025-12-31) — Amortization: 39224.00
SBIO.V cash_flow (annual, 2025-12-31) — Amortization Cash Flow: 172346.00
SBIO.V cash_flow (quarterly, 2025-12-31) — Amortization Cash Flow: 39224.00
SBIO.V cash_flow (annual, 2025-12-31) — Amortization Of Intangibles: 172346.00
SBIO.V cash_flow (quarterly, 2025-12-31) — Amortization Of Intangibles: 39224.00
SBIO.V income_statement (annual, 2025-12-31) — Amortization Of Intangibles Income Statement: 172346.00
SBIO.V income_statement (quarterly, 2025-12-31) — Amortization Of Intangibles Income Statement: 39224.00
SBIO.V income_statement (annual, 2025-12-31) — Basic Average Shares: 51201859.00
SBIO.V income_statement (annual, 2025-12-31) — Basic EPS: 0.19
SBIO.V cash_flow (annual, 2025-12-31) — Beginning Cash Position: 3300439.00
SBIO.V cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 1976770.00
SBIO.V balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 4404932.00
SBIO.V balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 4404932.00
SBIO.V cash_flow (annual, 2025-12-31) — Capital Expenditure: -86499.00
SBIO.V cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -13680.00
SBIO.V balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 2368173.00
SBIO.V balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 2368173.00
SBIO.V balance_sheet (annual, 2025-12-31) — Capital Stock: 14365539.00
SBIO.V balance_sheet (quarterly, 2025-12-31) — Capital Stock: 14365539.00
SBIO.V balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 1343131.00
SBIO.V balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 1343131.00
SBIO.V balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 1343131.00
SBIO.V balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 1343131.00
SBIO.V balance_sheet (annual, 2025-12-31) — Cash Financial: 1343131.00
SBIO.V balance_sheet (quarterly, 2025-12-31) — Cash Financial: 1343131.00
SBIO.V cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 4503475.00
SBIO.V cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 5008110.00
SBIO.V cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -86499.00
SBIO.V cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -13680.00
SBIO.V cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -6374284.00
SBIO.V cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -5628069.00
SBIO.V cash_flow (annual, 2025-12-31) — Change In Other Working Capital: 157296.00
SBIO.V cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: -19500.00
SBIO.V cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 55142.00
SBIO.V cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 2087956.00
SBIO.V cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: 16585.00
SBIO.V cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 50889.00
SBIO.V cash_flow (annual, 2025-12-31) — Change In Receivables: 1762330.00
SBIO.V cash_flow (quarterly, 2025-12-31) — Change In Receivables: -5248463.00
SBIO.V cash_flow (annual, 2025-12-31) — Change In Working Capital: 1991353.00
SBIO.V cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -3129118.00
SBIO.V cash_flow (annual, 2025-12-31) — Changes In Account Receivables: 1762330.00
SBIO.V cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -5248463.00
SBIO.V cash_flow (annual, 2025-12-31) — Changes In Cash: -1957308.00
SBIO.V cash_flow (quarterly, 2025-12-31) — Changes In Cash: -633639.00
SBIO.V balance_sheet (annual, 2025-12-31) — Common Stock: 14365539.00
SBIO.V balance_sheet (quarterly, 2025-12-31) — Common Stock: 14365539.00
SBIO.V balance_sheet (annual, 2025-12-31) — Common Stock Equity: -9627786.00
SBIO.V balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: -9627786.00
SBIO.V cash_flow (annual, 2025-12-31) — Common Stock Issuance: 764564.00
SBIO.V cash_flow (annual, 2025-12-31) — Common Stock Payments: 0.00
SBIO.V cash_flow (quarterly, 2025-12-31) — Common Stock Payments: 0.00
SBIO.V income_statement (annual, 2025-12-31) — Cost Of Revenue: 15477442.00
SBIO.V income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 4215592.00
SBIO.V balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 166788.00
SBIO.V balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 166788.00
SBIO.V balance_sheet (annual, 2025-12-31) — Current Assets: 15224608.00
SBIO.V balance_sheet (quarterly, 2025-12-31) — Current Assets: 15224608.00
SBIO.V balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 766580.00
SBIO.V balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 766580.00
SBIO.V balance_sheet (annual, 2025-12-31) — Current Debt: 10935074.00
SBIO.V balance_sheet (quarterly, 2025-12-31) — Current Debt: 10935074.00
SBIO.V balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 11701654.00
SBIO.V balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 11701654.00
SBIO.V balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 199500.00
SBIO.V balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 199500.00
SBIO.V balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 199500.00
SBIO.V balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 199500.00
SBIO.V balance_sheet (annual, 2025-12-31) — Current Liabilities: 27366758.00
SBIO.V balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 27366758.00
SBIO.V balance_sheet (annual, 2025-12-31) — Current Notes Payable: 1842318.00
SBIO.V balance_sheet (quarterly, 2025-12-31) — Current Notes Payable: 1842318.00
SBIO.V cash_flow (annual, 2025-12-31) — Depreciation: 694617.00
SBIO.V cash_flow (quarterly, 2025-12-31) — Depreciation: 185061.00
SBIO.V cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 866963.00
SBIO.V cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 224285.00
SBIO.V income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 866963.00
SBIO.V income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 224285.00
SBIO.V cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 866963.00
SBIO.V cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 224285.00
SBIO.V income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 866963.00
SBIO.V income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 224285.00
SBIO.V income_statement (annual, 2025-12-31) — Depreciation Income Statement: 694617.00
SBIO.V income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 185061.00
SBIO.V income_statement (annual, 2025-12-31) — Diluted Average Shares: 51201859.00
SBIO.V income_statement (annual, 2025-12-31) — Diluted EPS: 0.19
SBIO.V income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -9834993.00
SBIO.V income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -2817019.00
SBIO.V balance_sheet (annual, 2025-12-31) — Duefrom Related Parties Current: 32319.00
SBIO.V balance_sheet (quarterly, 2025-12-31) — Duefrom Related Parties Current: 32319.00
SBIO.V balance_sheet (annual, 2025-12-31) — Duefrom Related Parties Non Current: 0.00
SBIO.V balance_sheet (quarterly, 2025-12-31) — Duefrom Related Parties Non Current: 0.00
SBIO.V income_statement (annual, 2025-12-31) — EBIT: -8358611.00
SBIO.V income_statement (quarterly, 2025-12-31) — EBIT: -2337002.00
SBIO.V income_statement (annual, 2025-12-31) — EBITDA: -7491648.00
SBIO.V income_statement (quarterly, 2025-12-31) — EBITDA: -2112717.00
SBIO.V cash_flow (annual, 2025-12-31) — End Cash Position: 1343131.00
SBIO.V cash_flow (quarterly, 2025-12-31) — End Cash Position: 1343131.00
SBIO.V cash_flow (annual, 2025-12-31) — Financing Cash Flow: 4503475.00
SBIO.V cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 5008110.00
SBIO.V balance_sheet (annual, 2025-12-31) — Foreign Currency Translation Adjustments: -105513.00
SBIO.V balance_sheet (quarterly, 2025-12-31) — Foreign Currency Translation Adjustments: -105513.00
SBIO.V cash_flow (annual, 2025-12-31) — Free Cash Flow: -6460783.00
SBIO.V cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -5641749.00
SBIO.V balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -105513.00
SBIO.V balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -105513.00
SBIO.V income_statement (annual, 2025-12-31) — General And Administrative Expense: 7421997.00
SBIO.V income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 1843205.00
SBIO.V balance_sheet (annual, 2025-12-31) — Goodwill: 2478774.00
SBIO.V balance_sheet (quarterly, 2025-12-31) — Goodwill: 2478774.00
SBIO.V balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 2653149.00
SBIO.V balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 2653149.00
SBIO.V balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 13128112.00
SBIO.V balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 13128112.00
SBIO.V balance_sheet (annual, 2025-12-31) — Gross PPE: 4404932.00
SBIO.V balance_sheet (quarterly, 2025-12-31) — Gross PPE: 4404932.00
SBIO.V income_statement (annual, 2025-12-31) — Gross Profit: 22753955.00
SBIO.V income_statement (quarterly, 2025-12-31) — Gross Profit: 5563171.00
SBIO.V balance_sheet (annual, 2025-12-31) — Income Tax Payable: 71488.00
SBIO.V balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 71488.00
SBIO.V income_statement (annual, 2025-12-31) — Interest Expense: 1395878.00
SBIO.V income_statement (quarterly, 2025-12-31) — Interest Expense: 444032.00
SBIO.V income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 1395878.00
SBIO.V income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 444032.00
SBIO.V balance_sheet (annual, 2025-12-31) — Interest Payable: 166788.00
SBIO.V balance_sheet (quarterly, 2025-12-31) — Interest Payable: 166788.00
SBIO.V balance_sheet (annual, 2025-12-31) — Invested Capital: 1738663.00
SBIO.V balance_sheet (quarterly, 2025-12-31) — Invested Capital: 1738663.00
SBIO.V cash_flow (annual, 2025-12-31) — Investing Cash Flow: -86499.00
SBIO.V cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -13680.00
SBIO.V cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 764564.00
SBIO.V cash_flow (annual, 2025-12-31) — Issuance Of Debt: 4552916.00
SBIO.V balance_sheet (annual, 2025-12-31) — Line Of Credit: 9084131.00
SBIO.V balance_sheet (quarterly, 2025-12-31) — Line Of Credit: 9084131.00
SBIO.V balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 1601593.00
SBIO.V balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 1601593.00
SBIO.V balance_sheet (annual, 2025-12-31) — Long Term Debt: 431375.00
SBIO.V balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 431375.00
SBIO.V balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 2032968.00
SBIO.V balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 2032968.00
SBIO.V cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 4552916.00
SBIO.V cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -872597.00
SBIO.V cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -257867.00
SBIO.V cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 764564.00
SBIO.V cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 764564.00
SBIO.V balance_sheet (annual, 2025-12-31) — Net Debt: 10023318.00
SBIO.V balance_sheet (quarterly, 2025-12-31) — Net Debt: 10023318.00
SBIO.V cash_flow (annual, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: 13615.00
SBIO.V cash_flow (quarterly, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: -31495.00
SBIO.V income_statement (annual, 2025-12-31) — Net Income: -9834993.00
SBIO.V income_statement (quarterly, 2025-12-31) — Net Income: -2817019.00
SBIO.V income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -9834993.00
SBIO.V income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -2817019.00
SBIO.V income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -9834993.00
SBIO.V income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -2817019.00
SBIO.V income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -9834993.00
SBIO.V income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -2817019.00
SBIO.V income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -9834993.00
SBIO.V income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -2817019.00
SBIO.V cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -9834993.00
SBIO.V cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -2817019.00
SBIO.V income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -9834993.00
SBIO.V income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -2817019.00
SBIO.V cash_flow (annual, 2025-12-31) — Net Intangibles Purchase And Sale: -86499.00
SBIO.V cash_flow (quarterly, 2025-12-31) — Net Intangibles Purchase And Sale: -13680.00
SBIO.V income_statement (annual, 2025-12-31) — Net Interest Income: -1395878.00
SBIO.V income_statement (quarterly, 2025-12-31) — Net Interest Income: -444032.00
SBIO.V cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 3680319.00
SBIO.V cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 4181973.00
SBIO.V cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 3680319.00
SBIO.V cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: 4181973.00
SBIO.V income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -1395878.00
SBIO.V income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -444032.00
SBIO.V cash_flow (annual, 2025-12-31) — Net Other Financing Charges: 58592.00
SBIO.V cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: 61573.00
SBIO.V balance_sheet (annual, 2025-12-31) — Net PPE: 1894183.00
SBIO.V balance_sheet (quarterly, 2025-12-31) — Net PPE: 1894183.00
SBIO.V balance_sheet (annual, 2025-12-31) — Net Tangible Assets: -12280935.00
SBIO.V balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -12280935.00
SBIO.V balance_sheet (annual, 2025-12-31) — Non Current Note Receivables: 0.00
SBIO.V balance_sheet (quarterly, 2025-12-31) — Non Current Note Receivables: 0.00
SBIO.V income_statement (annual, 2025-12-31) — Normalized EBITDA: -8290390.00
SBIO.V income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -2339352.00
SBIO.V income_statement (annual, 2025-12-31) — Normalized Income: -10465999.18
SBIO.V income_statement (quarterly, 2025-12-31) — Normalized Income: -2996060.65
SBIO.V balance_sheet (annual, 2025-12-31) — Notes Receivable: 465355.00
SBIO.V balance_sheet (quarterly, 2025-12-31) — Notes Receivable: 465355.00
SBIO.V cash_flow (annual, 2025-12-31) — Operating Cash Flow: -6374284.00
SBIO.V cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -5628069.00
SBIO.V cash_flow (annual, 2025-12-31) — Operating Gains Losses: 21144.00
SBIO.V cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -31495.00
SBIO.V income_statement (annual, 2025-12-31) — Operating Income: -9149618.00
SBIO.V income_statement (quarterly, 2025-12-31) — Operating Income: -2563637.00
SBIO.V income_statement (annual, 2025-12-31) — Operating Revenue: 38231397.00
SBIO.V income_statement (quarterly, 2025-12-31) — Operating Revenue: 9778763.00
SBIO.V balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 54324349.00
SBIO.V balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 54324349.00
SBIO.V balance_sheet (annual, 2025-12-31) — Other Current Assets: 413936.00
SBIO.V balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 413936.00
SBIO.V balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 8625.00
SBIO.V balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 8625.00
SBIO.V balance_sheet (annual, 2025-12-31) — Other Equity Interest: 1778418.00
SBIO.V balance_sheet (quarterly, 2025-12-31) — Other Equity Interest: 1778418.00
SBIO.V income_statement (annual, 2025-12-31) — Other Gand A: 6297807.00
SBIO.V income_statement (quarterly, 2025-12-31) — Other Gand A: 1565895.00
SBIO.V income_statement (annual, 2025-12-31) — Other Income Expense: 791007.00
SBIO.V income_statement (quarterly, 2025-12-31) — Other Income Expense: 226635.00
SBIO.V balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 174375.00
SBIO.V balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 174375.00
SBIO.V cash_flow (annual, 2025-12-31) — Other Non Cash Items: 290639.00
SBIO.V cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 71358.00
SBIO.V income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: -7735.00
SBIO.V income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 0.00
SBIO.V income_statement (annual, 2025-12-31) — Other Special Charges: -798742.00
SBIO.V income_statement (quarterly, 2025-12-31) — Other Special Charges: -226635.00
SBIO.V balance_sheet (annual, 2025-12-31) — Payables: 15298816.00
SBIO.V balance_sheet (quarterly, 2025-12-31) — Payables: 15298816.00
SBIO.V balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 15465604.00
SBIO.V balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 15465604.00
SBIO.V income_statement (annual, 2025-12-31) — Pretax Income: -9754489.00
SBIO.V income_statement (quarterly, 2025-12-31) — Pretax Income: -2781034.00
SBIO.V cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 0.00
SBIO.V cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 0.00
SBIO.V balance_sheet (annual, 2025-12-31) — Properties: 0.00
SBIO.V balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
SBIO.V cash_flow (annual, 2025-12-31) — Purchase Of Intangibles: -86499.00
SBIO.V cash_flow (quarterly, 2025-12-31) — Purchase Of Intangibles: -13680.00
SBIO.V balance_sheet (annual, 2025-12-31) — Receivables: 13467541.00
SBIO.V balance_sheet (quarterly, 2025-12-31) — Receivables: 13467541.00
SBIO.V income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 15477442.00
SBIO.V income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 4215592.00
SBIO.V income_statement (annual, 2025-12-31) — Reconciled Depreciation: 866963.00
SBIO.V income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 224285.00
SBIO.V income_statement (annual, 2025-12-31) — Rent And Landing Fees: 842399.00
SBIO.V income_statement (quarterly, 2025-12-31) — Rent And Landing Fees: 224739.00
SBIO.V income_statement (annual, 2025-12-31) — Rent Expense Supplemental: 842399.00
SBIO.V income_statement (quarterly, 2025-12-31) — Rent Expense Supplemental: 224739.00
SBIO.V cash_flow (annual, 2025-12-31) — Repayment Of Debt: -872597.00
SBIO.V cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -257867.00
SBIO.V cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: 0.00
SBIO.V cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: 0.00
SBIO.V income_statement (annual, 2025-12-31) — Research And Development: 7362192.00
SBIO.V income_statement (quarterly, 2025-12-31) — Research And Development: 1947219.00
SBIO.V balance_sheet (annual, 2025-12-31) — Retained Earnings: -25666230.00
SBIO.V balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -25666230.00
SBIO.V income_statement (annual, 2025-12-31) — Salaries And Wages: 281791.00
SBIO.V income_statement (quarterly, 2025-12-31) — Salaries And Wages: 52571.00
SBIO.V income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 16252421.00
SBIO.V income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 4112099.00
SBIO.V income_statement (annual, 2025-12-31) — Selling General And Administration: 23674418.00
SBIO.V income_statement (quarterly, 2025-12-31) — Selling General And Administration: 5955304.00
SBIO.V balance_sheet (annual, 2025-12-31) — Share Issued: 54324349.00
SBIO.V balance_sheet (quarterly, 2025-12-31) — Share Issued: 54324349.00
SBIO.V income_statement (annual, 2025-12-31) — Special Income Charges: 798742.00
SBIO.V income_statement (quarterly, 2025-12-31) — Special Income Charges: 226635.00
SBIO.V cash_flow (annual, 2025-12-31) — Stock Based Compensation: 290610.00
SBIO.V cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 53920.00
SBIO.V balance_sheet (annual, 2025-12-31) — Stockholders Equity: -9627786.00
SBIO.V balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: -9627786.00
SBIO.V balance_sheet (annual, 2025-12-31) — Tangible Book Value: -12280935.00
SBIO.V balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -12280935.00
SBIO.V income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 167735.82
SBIO.V income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 47593.35
SBIO.V income_statement (annual, 2025-12-31) — Tax Provision: 80504.00
SBIO.V income_statement (quarterly, 2025-12-31) — Tax Provision: 35985.00
SBIO.V income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.21
SBIO.V income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.21
SBIO.V balance_sheet (annual, 2025-12-31) — Total Assets: 19771940.00
SBIO.V balance_sheet (quarterly, 2025-12-31) — Total Assets: 19771940.00
SBIO.V balance_sheet (annual, 2025-12-31) — Total Capitalization: -9196411.00
SBIO.V balance_sheet (quarterly, 2025-12-31) — Total Capitalization: -9196411.00
SBIO.V balance_sheet (annual, 2025-12-31) — Total Debt: 13734622.00
SBIO.V balance_sheet (quarterly, 2025-12-31) — Total Debt: 13734622.00
SBIO.V balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: -9627786.00
SBIO.V balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: -9627786.00
SBIO.V income_statement (annual, 2025-12-31) — Total Expenses: 47381015.00
SBIO.V income_statement (quarterly, 2025-12-31) — Total Expenses: 12342400.00
SBIO.V balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 29399726.00
SBIO.V balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 29399726.00
SBIO.V balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 4547332.00
SBIO.V balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 4547332.00
SBIO.V balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 2032968.00
SBIO.V balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 2032968.00
SBIO.V income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -9149618.00
SBIO.V income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -2563637.00
SBIO.V balance_sheet (annual, 2025-12-31) — Total Tax Payable: 71488.00
SBIO.V balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 71488.00
SBIO.V income_statement (annual, 2025-12-31) — Total Unusual Items: 798742.00
SBIO.V income_statement (quarterly, 2025-12-31) — Total Unusual Items: 226635.00
SBIO.V income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 798742.00
SBIO.V income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 226635.00
SBIO.V balance_sheet (annual, 2025-12-31) — Treasury Stock: 0.00
SBIO.V balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 0.00
SBIO.V balance_sheet (annual, 2025-12-31) — Working Capital: -12142150.00
SBIO.V balance_sheet (quarterly, 2025-12-31) — Working Capital: -12142150.00
SBIO.V income_statement (quarterly, 2026-03-31) — +Operating Expense: 7724622.00
SBIO.V income_statement (quarterly, 2026-03-31) — +Total Revenue: 7158342.00
SBIO.V balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 18309915.00
SBIO.V balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 9103712.00
SBIO.V balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -2691786.00
SBIO.V balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -173982.00
SBIO.V income_statement (quarterly, 2026-03-31) — Amortization: 35861.00
SBIO.V cash_flow (quarterly, 2026-03-31) — Amortization Cash Flow: 35861.00
SBIO.V cash_flow (quarterly, 2026-03-31) — Amortization Of Intangibles: 35861.00
SBIO.V income_statement (quarterly, 2026-03-31) — Amortization Of Intangibles Income Statement: 35861.00
SBIO.V income_statement (quarterly, 2026-03-31) — Basic Average Shares: 54350111.00
SBIO.V income_statement (quarterly, 2026-03-31) — Basic EPS: -0.08
SBIO.V cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 1343131.00
SBIO.V balance_sheet (quarterly, 2026-03-31) — Buildings And Improvements: 4404932.00
SBIO.V cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -39343.00
SBIO.V balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 2174400.00
SBIO.V balance_sheet (quarterly, 2026-03-31) — Capital Stock: 14509845.00
SBIO.V balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 1046338.00
SBIO.V balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 1046338.00
SBIO.V balance_sheet (quarterly, 2026-03-31) — Cash Financial: 1046338.00
SBIO.V cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -3139027.00
SBIO.V cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -39343.00
SBIO.V cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 2881577.00
SBIO.V cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: 2188.00
SBIO.V cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 3087460.00
SBIO.V cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -153625.00
SBIO.V cash_flow (quarterly, 2026-03-31) — Change In Receivables: 3866155.00
SBIO.V cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 6802178.00
SBIO.V cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: 3866155.00
SBIO.V cash_flow (quarterly, 2026-03-31) — Changes In Cash: -296793.00
SBIO.V balance_sheet (quarterly, 2026-03-31) — Common Stock: 14509845.00
SBIO.V balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: -13829333.00
SBIO.V income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 3347166.00
SBIO.V balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 151513.00
SBIO.V balance_sheet (quarterly, 2026-03-31) — Current Assets: 11215334.00
SBIO.V balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 796541.00
SBIO.V balance_sheet (quarterly, 2026-03-31) — Current Debt: 8057302.00
SBIO.V balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 8853843.00
SBIO.V balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 201688.00
SBIO.V balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 201688.00
SBIO.V balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 27608595.00
SBIO.V balance_sheet (quarterly, 2026-03-31) — Current Notes Payable: 1798248.00
SBIO.V cash_flow (quarterly, 2026-03-31) — Depreciation: 181037.00
SBIO.V cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 216898.00
SBIO.V income_statement (quarterly, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 216898.00
SBIO.V cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 216898.00
SBIO.V income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 216898.00
SBIO.V income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 181037.00
SBIO.V income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 54350111.00
SBIO.V income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.08
SBIO.V income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -4419791.00
SBIO.V balance_sheet (quarterly, 2026-03-31) — Duefrom Related Parties Current: 32368.00
SBIO.V income_statement (quarterly, 2026-03-31) — EBIT: -3912652.00
SBIO.V income_statement (quarterly, 2026-03-31) — EBITDA: -3695754.00
SBIO.V cash_flow (quarterly, 2026-03-31) — End Cash Position: 1046338.00
SBIO.V cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -3139027.00
SBIO.V balance_sheet (quarterly, 2026-03-31) — Foreign Currency Translation Adjustments: -68260.00
SBIO.V cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 2842234.00
SBIO.V cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: 131712.00
SBIO.V balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -68260.00
SBIO.V income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 1657621.00
SBIO.V balance_sheet (quarterly, 2026-03-31) — Goodwill: 2478774.00
SBIO.V balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 2656631.00
SBIO.V balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 9277694.00
SBIO.V balance_sheet (quarterly, 2026-03-31) — Gross PPE: 4404932.00
SBIO.V income_statement (quarterly, 2026-03-31) — Gross Profit: 3811176.00
SBIO.V balance_sheet (quarterly, 2026-03-31) — Income Tax Payable: 91636.00
SBIO.V income_statement (quarterly, 2026-03-31) — Interest Expense: 486738.00
SBIO.V income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 486738.00
SBIO.V balance_sheet (quarterly, 2026-03-31) — Interest Payable: 151513.00
SBIO.V balance_sheet (quarterly, 2026-03-31) — Invested Capital: -5344041.00
SBIO.V cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -39343.00
SBIO.V balance_sheet (quarterly, 2026-03-31) — Line Of Credit: 6247044.00
SBIO.V balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 1377859.00
SBIO.V balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 427990.00
SBIO.V balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 1805849.00
SBIO.V cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -257821.00
SBIO.V balance_sheet (quarterly, 2026-03-31) — Net Debt: 7438954.00
SBIO.V cash_flow (quarterly, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: 37253.00
SBIO.V income_statement (quarterly, 2026-03-31) — Net Income: -4419791.00
SBIO.V income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -4419791.00
SBIO.V income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -4419791.00
SBIO.V income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -4419791.00
SBIO.V income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -4419791.00
SBIO.V cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -4419791.00
SBIO.V income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -4419791.00
SBIO.V cash_flow (quarterly, 2026-03-31) — Net Intangibles Purchase And Sale: -39343.00
SBIO.V income_statement (quarterly, 2026-03-31) — Net Interest Income: -486738.00
SBIO.V cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -3138978.00
SBIO.V cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -3138978.00
SBIO.V income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -486738.00
SBIO.V cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -49.00
SBIO.V balance_sheet (quarterly, 2026-03-31) — Net PPE: 1713146.00
SBIO.V balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: -16485964.00
SBIO.V income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -3695754.00
SBIO.V income_statement (quarterly, 2026-03-31) — Normalized Income: -4419791.00
SBIO.V balance_sheet (quarterly, 2026-03-31) — Notes Receivable: 466069.00
SBIO.V cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 2881577.00
SBIO.V cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 168965.00
SBIO.V income_statement (quarterly, 2026-03-31) — Operating Income: -3913446.00
SBIO.V income_statement (quarterly, 2026-03-31) — Operating Revenue: 7158342.00
SBIO.V balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 54356334.00
SBIO.V balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 566847.00
SBIO.V balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 12010.00
SBIO.V balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 1815103.00
SBIO.V income_statement (quarterly, 2026-03-31) — Other Gand A: 1394762.00
SBIO.V income_statement (quarterly, 2026-03-31) — Other Income Expense: 794.00
SBIO.V balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 177857.00
SBIO.V cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 64048.00
SBIO.V income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 794.00
SBIO.V balance_sheet (quarterly, 2026-03-31) — Payables: 18401551.00
SBIO.V balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 18553064.00
SBIO.V income_statement (quarterly, 2026-03-31) — Pretax Income: -4399390.00
SBIO.V balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
SBIO.V cash_flow (quarterly, 2026-03-31) — Purchase Of Intangibles: -39343.00
SBIO.V balance_sheet (quarterly, 2026-03-31) — Receivables: 9602149.00
SBIO.V income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 3347166.00
SBIO.V income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 216898.00
SBIO.V income_statement (quarterly, 2026-03-31) — Rent And Landing Fees: 214138.00
SBIO.V income_statement (quarterly, 2026-03-31) — Rent Expense Supplemental: 214138.00
SBIO.V cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -257821.00
SBIO.V income_statement (quarterly, 2026-03-31) — Research And Development: 1973485.00
SBIO.V balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -30086021.00
SBIO.V income_statement (quarterly, 2026-03-31) — Salaries And Wages: 48721.00
SBIO.V income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 3876618.00
SBIO.V income_statement (quarterly, 2026-03-31) — Selling General And Administration: 5534239.00
SBIO.V balance_sheet (quarterly, 2026-03-31) — Share Issued: 54356334.00
SBIO.V income_statement (quarterly, 2026-03-31) — Special Income Charges: 0.00
SBIO.V cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 49279.00
SBIO.V balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: -13829333.00
SBIO.V balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: -16485964.00
SBIO.V income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
SBIO.V income_statement (quarterly, 2026-03-31) — Tax Provision: 20401.00
SBIO.V income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
SBIO.V balance_sheet (quarterly, 2026-03-31) — Total Assets: 15585111.00
SBIO.V balance_sheet (quarterly, 2026-03-31) — Total Capitalization: -13401343.00
SBIO.V balance_sheet (quarterly, 2026-03-31) — Total Debt: 10659692.00
SBIO.V balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: -13829333.00
SBIO.V income_statement (quarterly, 2026-03-31) — Total Expenses: 11071788.00
SBIO.V balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 29414444.00
SBIO.V balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 4369777.00
SBIO.V balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 1805849.00
SBIO.V income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -3913446.00
SBIO.V balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 91636.00
SBIO.V income_statement (quarterly, 2026-03-31) — Total Unusual Items: 0.00
SBIO.V income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 0.00
SBIO.V balance_sheet (quarterly, 2026-03-31) — Working Capital: -16393261.00
SBLK balance_sheet (annual, 2021-12-31) — Allowance For Doubtful Accounts Receivable: -629000.00
SBLK balance_sheet (annual, 2021-12-31) — Derivative Product Liabilities: 0.00
SBLK balance_sheet (annual, 2021-12-31) — Income Tax Payable: 60000.00
SBLK balance_sheet (annual, 2021-12-31) — Other Current Liabilities: 743000.00
SBLK balance_sheet (annual, 2021-12-31) — Prepaid Assets: 28659000.00
SBLK income_statement (annual, 2021-12-31) — Provision For Doubtful Accounts: 629000.00
SBLK cash_flow (annual, 2021-12-31) — Provisionand Write Offof Assets: 629000.00
SBLK balance_sheet (annual, 2021-12-31) — Total Tax Payable: 60000.00
SBLK balance_sheet (annual, 2021-12-31) — Treasury Stock: 0.00
SBLK income_statement (annual, 2022-12-31) — +Operating Expense: 48032000.00
SBLK income_statement (annual, 2022-12-31) — +Total Revenue: 1437156000.00
SBLK balance_sheet (annual, 2022-12-31) — Accounts Payable: 32140000.00
SBLK balance_sheet (annual, 2022-12-31) — Accounts Receivable: 84034000.00
SBLK balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -962135000.00
SBLK balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 2646073000.00
SBLK balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -677000.00
SBLK cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 18610000.00
SBLK balance_sheet (annual, 2022-12-31) — Assets Held For Sale Current: 0.00
SBLK income_statement (annual, 2022-12-31) — Basic Average Shares: 102153255.00
SBLK income_statement (annual, 2022-12-31) — Basic EPS: 5.54
SBLK cash_flow (annual, 2022-12-31) — Beginning Cash Position: 473271000.00
SBLK balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 37618000.00
SBLK cash_flow (annual, 2022-12-31) — Capital Expenditure: -25403000.00
SBLK balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 228217000.00
SBLK balance_sheet (annual, 2022-12-31) — Capital Stock: 1029000.00
SBLK balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 269754000.00
SBLK balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 269754000.00
SBLK cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -668697000.00
SBLK cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -935953000.00
SBLK cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -20872000.00
SBLK cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 769898000.00
SBLK cash_flow (annual, 2022-12-31) — Change In Account Payable: 11563000.00
SBLK cash_flow (annual, 2022-12-31) — Change In Accrued Expense: 4031000.00
SBLK cash_flow (annual, 2022-12-31) — Change In Inventory: -9411000.00
SBLK cash_flow (annual, 2022-12-31) — Change In Other Current Assets: -91000.00
SBLK cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: -10638000.00
SBLK cash_flow (annual, 2022-12-31) — Change In Other Working Capital: -8276000.00
SBLK cash_flow (annual, 2022-12-31) — Change In Payable: 14097000.00
SBLK cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 18128000.00
SBLK cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: -3818000.00
SBLK cash_flow (annual, 2022-12-31) — Change In Receivables: 5606000.00
SBLK cash_flow (annual, 2022-12-31) — Change In Working Capital: -8500000.00
SBLK cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -3650000.00
SBLK cash_flow (annual, 2022-12-31) — Changes In Cash: -186927000.00
SBLK balance_sheet (annual, 2022-12-31) — Common Stock: 1029000.00
SBLK cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -668697000.00
SBLK balance_sheet (annual, 2022-12-31) — Common Stock Equity: 2019342000.00
SBLK cash_flow (annual, 2022-12-31) — Common Stock Issuance: 19792000.00
SBLK cash_flow (annual, 2022-12-31) — Common Stock Payments: -20068000.00
SBLK income_statement (annual, 2022-12-31) — Cost Of Revenue: 759692000.00
SBLK balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 33734000.00
SBLK balance_sheet (annual, 2022-12-31) — Current Assets: 502092000.00
SBLK balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 25316000.00
SBLK balance_sheet (annual, 2022-12-31) — Current Debt: 166586000.00
SBLK balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 191902000.00
SBLK balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 16684000.00
SBLK balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 16684000.00
SBLK balance_sheet (annual, 2022-12-31) — Current Liabilities: 282555000.00
SBLK cash_flow (annual, 2022-12-31) — Depreciation: 156733000.00
SBLK cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 156733000.00
SBLK cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 156733000.00
SBLK income_statement (annual, 2022-12-31) — Diluted Average Shares: 102536966.00
SBLK income_statement (annual, 2022-12-31) — Diluted EPS: 5.52
SBLK income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 565999000.00
SBLK balance_sheet (annual, 2022-12-31) — Duefrom Related Parties Current: 408000.00
SBLK balance_sheet (annual, 2022-12-31) — Dueto Related Parties Current: 7845000.00
SBLK income_statement (annual, 2022-12-31) — EBIT: 622671000.00
SBLK income_statement (annual, 2022-12-31) — EBITDA: 779404000.00
SBLK income_statement (annual, 2022-12-31) — Earnings From Equity Interest Net Of Tax: 109000.00
SBLK cash_flow (annual, 2022-12-31) — Earnings Losses From Equity Investments: -109000.00
SBLK cash_flow (annual, 2022-12-31) — End Cash Position: 286344000.00
SBLK balance_sheet (annual, 2022-12-31) — Financial Assets: 8666000.00
SBLK cash_flow (annual, 2022-12-31) — Financing Cash Flow: -935953000.00
SBLK cash_flow (annual, 2022-12-31) — Free Cash Flow: 744495000.00
SBLK cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: -2583000.00
SBLK cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: 0.00
SBLK income_statement (annual, 2022-12-31) — Gain On Sale Of Ppe: 0.00